CN109260447A - A kind of Chinese medicine composition for treating cardiovascular disease - Google Patents
A kind of Chinese medicine composition for treating cardiovascular disease Download PDFInfo
- Publication number
- CN109260447A CN109260447A CN201811472476.XA CN201811472476A CN109260447A CN 109260447 A CN109260447 A CN 109260447A CN 201811472476 A CN201811472476 A CN 201811472476A CN 109260447 A CN109260447 A CN 109260447A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- fermented tea
- cardiovascular disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine compositions for treating cardiovascular disease, Chinese medicine composition is made of ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea, the component of parts by weight are as follows: 3~7 parts of ginseng；2~6 parts of Cortex Eucommiae；1~5 part of puncture vine；3~6 parts of rhizoma polygonati；4~7 parts of longspur epimedium；5~10 parts of Radix Salviae Miltiorrhizae；8~15 parts of safflower；6~10 parts of root of kirilow rhodiola.Composition prepared by the present invention is pure Chinese medicinal preparation, remove patient from and takes Western medicine throughout the year, generate the pain of complication, and this composition can effectively improve the symptoms such as hypertension, hyperlipidemia, uric acid, can purify body-internal-circulation, prevention vascular sclerosis, induction tumour decline it, anti-oxidant, antibacterial, anticoagulation, anti-ageing, without side-effects to body, quick and effect is good.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, specially a kind of without side-effects, and can quickly treat in cardiovascular disease
Drug composition.
Background technique
Cardiovascular disease, also known as circulation system disease refer to that a series of diseases of the circulatory system, the circulatory system refer to human body
Interior hemophoric organ and tissue, can be subdivided into it is acute and chronic, with high illness rate, high disability rate and high mortality
Feature seriously endangers the life quality of general public, and heavy society and financial burden are brought to China, cardiovascular in treatment
In disease, Western medicine is used mostly, but Western medicine there is side effects phenomenon big, easy to recur and slow curative effect, for this purpose, it is proposed that one
The Chinese medicine composition of kind treatment cardiovascular disease.
Summary of the invention
The purpose of the present invention is to provide a kind of Chinese medicine compositions for treating cardiovascular disease, to solve above-mentioned background technique
The problem of middle proposition.
To achieve the above object, the invention provides the following technical scheme: a kind of Chinese medicine composition for treating cardiovascular disease,
Chinese medicine composition is by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, fourth
Perfume, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea composition, the component of parts by weight are as follows: ginseng 3~
7 parts；2~6 parts of Cortex Eucommiae；1~5 part of puncture vine；3~6 parts of rhizoma polygonati；4~7 parts of longspur epimedium；5~10 parts of Radix Salviae Miltiorrhizae；8~15 parts of safflower；It is red
6~10 parts of red-spotted stonecrop；15~25 parts of Radix Notoginseng；10~20 parts of radix cyathulae；3~7 parts of raspberry；8~15 parts of cloves；2~5 parts of cortex cinnamomi；
20~30 parts of rhizoma zingiberis；15~30 parts of dandelion；3~8 parts of radix aucklandiae；7~15 parts of cogongrass cliff berry；6~12 parts of Heiguteng exract；Fermented tea 50~
90 parts.
Preferably, the Chinese medicine composition is by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, three
Seven, radix cyathulae, raspberry, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea composition, weight
The component of number are as follows: 4~6 parts of ginseng；3~5 parts of Cortex Eucommiae；2~4 parts of puncture vine；4~6 parts of rhizoma polygonati；5~7 parts of longspur epimedium；Radix Salviae Miltiorrhizae 6~
9 parts；10~14 parts of safflower；7~9 parts of root of kirilow rhodiola；18~22 parts of Radix Notoginseng；14~18 parts of radix cyathulae；4~6 parts of raspberry；Cloves 10
~12 parts；3~5 parts of cortex cinnamomi；24~26 parts of rhizoma zingiberis；22~24 parts of dandelion；4~6 parts of radix aucklandiae；11~13 parts of cogongrass cliff berry；Black bone
8~10 parts of rattan；60~80 parts of fermented tea.
Preferably, the Chinese medicine composition is by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, three
Seven, radix cyathulae, raspberry, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea composition, weight
The component of number are as follows: 5 parts of ginseng；4 parts of Cortex Eucommiae；3 parts of puncture vine；5 parts of rhizoma polygonati；6 parts of longspur epimedium；8 parts of Radix Salviae Miltiorrhizae；12 parts of safflower；Red scape
It 8 parts；20 parts of Radix Notoginseng；16 parts of radix cyathulae；5 parts of raspberry；11 parts of cloves；4 parts of cortex cinnamomi；25 parts of rhizoma zingiberis；23 parts of dandelion；Radix aucklandiae
5 parts；12 parts of cogongrass cliff berry；9 parts of Heiguteng exract；70 parts of fermented tea.
Preferably, preparation method includes the following steps:
A, it sorting: chooses ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, cover
Basin, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea；
B, it cleans: selected raw material being separately put into trash extraction box and carries out removal of impurities processing；
C, it filters: considering except the harmful substance in fermented tea；
D, it extracts: each raw material in addition to fermented tea is put into parts by weight in extracter and carries out extraction processing；
E, it ferments: the fermented tea of parts by weight being put into extract liquor and carries out fermentation process；
F, broken wall treatment broken wall: is carried out to the mixed liquor after fermentation；
G, filling: the mixed liquor after broken wall is subjected to filling process with bottle placer；
H, it is packed and stored after the assay was approved.
Preferably, the harmful substance in the step C includes Aspergillus flavus and harmful bacteria.
Preferably, the extraction temperature in the step D controls between 100~120 DEG C, and pressure is controlled in 25~30MPa
Between, the time controls between 1~2h.
Preferably, the fermentation temperature in the step E controls between 25~30 DEG C, and fermentation time is controlled in 20~40d
Between.
Preferably, the broken wall of the step F carries out in pulverizer, and the mating sieve for being provided with 400~600 mesh of pulverizer
Net.
Preferably, in the step G, every bottle of filling mixing liquid hold-up is between 10~20ml.
Compared with prior art, beneficial effects of the present invention are as follows:
Composition prepared by the present invention is pure Chinese medicinal preparation, removes patient from and takes Western medicine throughout the year, generates the pain of complication
It is hard can to purify body-internal-circulation, prevention blood vessel for hardship, and this composition can effectively improve the symptoms such as hypertension, hyperlipidemia, uric acid
Change, induction tumour decline it, anti-oxidant, antibacterial, anticoagulation, anti-ageing, without side-effects to body, quick and effect is good.
Detailed description of the invention
Fig. 1 is schematic structural view of the invention；
Fig. 2 is the embodiment of the present invention and comparative example table schematic diagram.
Specific embodiment
Following will be combined with the drawings in the embodiments of the present invention, and technical solution in the embodiment of the present invention carries out clear, complete
Site preparation description, it is clear that described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, it is obtained by those of ordinary skill in the art without making creative efforts every other
Embodiment shall fall within the protection scope of the present invention.
Embodiment one:
A kind of Chinese medicine composition for treating cardiovascular disease, Chinese medicine composition is by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, excessive sheep
Suddenly, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, black bone
Rattan and fermented tea composition, composition is pure Chinese medicinal preparation, removes patient from and takes Western medicine throughout the year, generates the pain of complication, and this
Composition can effectively improve the symptoms such as hypertension, hyperlipidemia, uric acid, can purify body-internal-circulation, prevention vascular sclerosis, induce and swell
Tumor decline it, anti-oxidant, antibacterial, anticoagulation, anti-ageing, without side-effects to body, quick and effect is good, the component of parts by weight
Are as follows: 3~7 parts of ginseng；2~6 parts of Cortex Eucommiae；1~5 part of puncture vine；3~6 parts of rhizoma polygonati；4~7 parts of longspur epimedium；5~10 parts of Radix Salviae Miltiorrhizae；Safflower 8
~15 parts；6~10 parts of root of kirilow rhodiola；15~25 parts of Radix Notoginseng；10~20 parts of radix cyathulae；3~7 parts of raspberry；8~15 parts of cloves；Meat
2~5 parts of osmanthus；20~30 parts of rhizoma zingiberis；15~30 parts of dandelion；3~8 parts of radix aucklandiae；7~15 parts of cogongrass cliff berry；6~12 parts of Heiguteng exract；
50~90 parts of fermented tea.
Preparation method includes the following steps:
A, it sorting: chooses ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, cover
Basin, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea；
B, it cleans: selected raw material being separately put into trash extraction box and carries out removal of impurities processing；
C, it filters: considering except the harmful substance in fermented tea；
D, it extracts: each raw material in addition to fermented tea is put into parts by weight in extracter and carries out extraction processing；
E, it ferments: the fermented tea of parts by weight being put into extract liquor and carries out fermentation process；
F, broken wall treatment broken wall: is carried out to the mixed liquor after fermentation；
G, filling: the mixed liquor after broken wall is subjected to filling process with bottle placer；
H, it is packed and stored after the assay was approved, active factors EGCG in tea can be made to increase by 10 times.
Harmful substance in step C includes Aspergillus flavus and harmful bacteria.
Extraction temperature in step D is 100 DEG C, pressure 30MPa, time 1h.
Fermentation temperature in step E is 25 DEG C, fermentation time 40d.
The broken wall of step F carries out in pulverizer, and the mating sieve for being provided with 400 mesh of pulverizer.
In step G, every bottle of filling mixing liquid hold-up is 10ml.
Embodiment two:
A kind of Chinese medicine composition for treating cardiovascular disease, Chinese medicine composition is by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, excessive sheep
Suddenly, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, black bone
Rattan and fermented tea composition, composition is pure Chinese medicinal preparation, removes patient from and takes Western medicine throughout the year, generates the pain of complication, and this
Composition can effectively improve the symptoms such as hypertension, hyperlipidemia, uric acid, can purify body-internal-circulation, prevention vascular sclerosis, induce and swell
Tumor decline it, anti-oxidant, antibacterial, anticoagulation, anti-ageing, without side-effects to body, quick and effect is good, the component of parts by weight
Are as follows: 4~6 parts of ginseng；3~5 parts of Cortex Eucommiae；2~4 parts of puncture vine；4~6 parts of rhizoma polygonati；5~7 parts of longspur epimedium；6~9 parts of Radix Salviae Miltiorrhizae；Safflower 10
~14 parts；7~9 parts of root of kirilow rhodiola；18~22 parts of Radix Notoginseng；14~18 parts of radix cyathulae；4~6 parts of raspberry；10~12 parts of cloves；Meat
3~5 parts of osmanthus；24~26 parts of rhizoma zingiberis；22~24 parts of dandelion；4~6 parts of radix aucklandiae；11~13 parts of cogongrass cliff berry；8~10 parts of Heiguteng exract；
60~80 parts of fermented tea.
Preparation method includes the following steps:
A, it sorting: chooses ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, cover
Basin, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea；
B, it cleans: selected raw material being separately put into trash extraction box and carries out removal of impurities processing；
C, it filters: considering except the harmful substance in fermented tea；
D, it extracts: each raw material in addition to fermented tea is put into parts by weight in extracter and carries out extraction processing；
E, it ferments: the fermented tea of parts by weight being put into extract liquor and carries out fermentation process；
F, broken wall treatment broken wall: is carried out to the mixed liquor after fermentation；
G, filling: the mixed liquor after broken wall is subjected to filling process with bottle placer；
H, it is packed and stored after the assay was approved, active factors EGCG in tea can be made to increase by 10 times.
Harmful substance in step C includes Aspergillus flavus and harmful bacteria.
Extraction temperature in step D is 110 DEG C, pressure 28MPa, time 1.5h.
Fermentation temperature in step E is 28 DEG C, fermentation time 30d.
The broken wall of step F carries out in pulverizer, and the mating sieve for being provided with 500 mesh of pulverizer.
In step G, every bottle of filling mixing liquid hold-up is 15ml.
Embodiment three:
A kind of Chinese medicine composition for treating cardiovascular disease, Chinese medicine composition is by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, excessive sheep
Suddenly, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, black bone
Rattan and fermented tea composition, composition is pure Chinese medicinal preparation, removes patient from and takes Western medicine throughout the year, generates the pain of complication, and this
Composition can effectively improve the symptoms such as hypertension, hyperlipidemia, uric acid, can purify body-internal-circulation, prevention vascular sclerosis, induce and swell
Tumor decline it, anti-oxidant, antibacterial, anticoagulation, anti-ageing, without side-effects to body, quick and effect is good, the component of parts by weight
Are as follows: 5 parts of ginseng；4 parts of Cortex Eucommiae；3 parts of puncture vine；5 parts of rhizoma polygonati；6 parts of longspur epimedium；8 parts of Radix Salviae Miltiorrhizae；12 parts of safflower；8 parts of root of kirilow rhodiola；Radix Notoginseng
20 parts；16 parts of radix cyathulae；5 parts of raspberry；11 parts of cloves；4 parts of cortex cinnamomi；25 parts of rhizoma zingiberis；23 parts of dandelion；5 parts of radix aucklandiae；Cogongrass cliff berry
12 parts；9 parts of Heiguteng exract；70 parts of fermented tea.
Preparation method includes the following steps:
A, it sorting: chooses ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, cover
Basin, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea；
B, it cleans: selected raw material being separately put into trash extraction box and carries out removal of impurities processing；
C, it filters: considering except the harmful substance in fermented tea；
D, it extracts: each raw material in addition to fermented tea is put into parts by weight in extracter and carries out extraction processing；
E, it ferments: the fermented tea of parts by weight being put into extract liquor and carries out fermentation process；
F, broken wall treatment broken wall: is carried out to the mixed liquor after fermentation；
G, filling: the mixed liquor after broken wall is subjected to filling process with bottle placer；
H, it is packed and stored after the assay was approved, active factors EGCG in tea can be made to increase by 10 times.
Harmful substance in step C includes Aspergillus flavus and harmful bacteria.
Extraction temperature in step D is 120 DEG C, pressure 25MPa, time 2h.
Fermentation temperature in step E is 30 DEG C, fermentation time 20d.
The broken wall of step F carries out in pulverizer, and the mating sieve for being provided with 600 mesh of pulverizer.
In step G, every bottle of filling mixing liquid hold-up is 20ml.
In use, composition is pure Chinese medicinal preparation, removes patient from and take Western medicine throughout the year, generates the pain of complication, and this
Composition can effectively improve the symptoms such as hypertension, hyperlipidemia, uric acid, can purify body-internal-circulation, prevention vascular sclerosis, induce and swell
Tumor decline it, anti-oxidant, antibacterial, anticoagulation, anti-ageing, without side-effects to body, quick and effect is good.
It although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, can be with
A variety of variations, modification, replacement can be carried out to these embodiments without departing from the principles and spirit of the present invention by understanding
And modification, the scope of the present invention is defined by the appended.
Claims (9)
1. a kind of Chinese medicine composition for treating cardiovascular disease, it is characterised in that: Chinese medicine composition is by ginseng, Cortex Eucommiae, puncture vine, Huang
Essence, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, Mao Yan
The certain kind of berries, Heiguteng exract and fermented tea composition, the component of parts by weight are as follows: 3~7 parts of ginseng；2~6 parts of Cortex Eucommiae；1~5 part of puncture vine；It is yellow
3~6 parts of essence；4~7 parts of longspur epimedium；5~10 parts of Radix Salviae Miltiorrhizae；8~15 parts of safflower；6~10 parts of root of kirilow rhodiola；15~25 parts of Radix Notoginseng；River ox
10~20 parts of knee；3~7 parts of raspberry；8~15 parts of cloves；2~5 parts of cortex cinnamomi；20~30 parts of rhizoma zingiberis；15~30 parts of dandelion；Wood
It is 3~8 parts fragrant；7~15 parts of cogongrass cliff berry；6~12 parts of Heiguteng exract；50~90 parts of fermented tea.
2. a kind of Chinese medicine composition for treating cardiovascular disease according to claim 1, it is characterised in that: the Chinese medicine group
Object is closed by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, cloves, meat
Osmanthus, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea composition, the component of parts by weight are as follows: 4~6 parts of ginseng；
3~5 parts of Cortex Eucommiae；2~4 parts of puncture vine；4~6 parts of rhizoma polygonati；5~7 parts of longspur epimedium；6~9 parts of Radix Salviae Miltiorrhizae；10~14 parts of safflower；Root of kirilow rhodiola 7
~9 parts；18~22 parts of Radix Notoginseng；14~18 parts of radix cyathulae；4~6 parts of raspberry；10~12 parts of cloves；3~5 parts of cortex cinnamomi；Rhizoma zingiberis 24
~26 parts；22~24 parts of dandelion；4~6 parts of radix aucklandiae；11~13 parts of cogongrass cliff berry；8~10 parts of Heiguteng exract；60~80 parts of fermented tea.
3. a kind of Chinese medicine composition for treating cardiovascular disease according to claim 1, it is characterised in that: the Chinese medicine group
Object is closed by ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, raspberry, cloves, meat
Osmanthus, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea composition, the component of parts by weight are as follows: 5 parts of ginseng；Cortex Eucommiae
4 parts；3 parts of puncture vine；5 parts of rhizoma polygonati；6 parts of longspur epimedium；8 parts of Radix Salviae Miltiorrhizae；12 parts of safflower；8 parts of root of kirilow rhodiola；20 parts of Radix Notoginseng；16 parts of radix cyathulae；
5 parts of raspberry；11 parts of cloves；4 parts of cortex cinnamomi；25 parts of rhizoma zingiberis；23 parts of dandelion；5 parts of radix aucklandiae；12 parts of cogongrass cliff berry；9 parts of Heiguteng exract；
70 parts of fermented tea.
4. a kind of Chinese medicine composition for treating cardiovascular disease according to any one of claims 1 to 3, it is characterised in that:
Preparation method includes the following steps:
A, it sorting: chooses ginseng, Cortex Eucommiae, puncture vine, rhizoma polygonati, longspur epimedium, Radix Salviae Miltiorrhizae, safflower, root of kirilow rhodiola, Radix Notoginseng, radix cyathulae, cover basin
Son, cloves, cortex cinnamomi, rhizoma zingiberis, dandelion, radix aucklandiae, cogongrass cliff berry, Heiguteng exract and fermented tea；
B, it cleans: selected raw material being separately put into trash extraction box and carries out removal of impurities processing；
C, it filters: considering except the harmful substance in fermented tea；
D, it extracts: each raw material in addition to fermented tea is put into parts by weight in extracter and carries out extraction processing；
E, it ferments: the fermented tea of parts by weight being put into extract liquor and carries out fermentation process；
F, broken wall treatment broken wall: is carried out to the mixed liquor after fermentation；
G, filling: the mixed liquor after broken wall is subjected to filling process with bottle placer；
H, it is packed and stored after the assay was approved.
5. a kind of Chinese medicine composition for treating cardiovascular disease according to claim 1, it is characterised in that: the step C
In harmful substance include Aspergillus flavus and harmful bacteria.
6. a kind of Chinese medicine composition for treating cardiovascular disease according to claim 1, it is characterised in that: the step D
In extraction temperature control between 100~120 DEG C, pressure control between 25~30MPa, the time control between 1~2h.
7. a kind of Chinese medicine composition for treating cardiovascular disease according to claim 1, it is characterised in that: the step E
In fermentation temperature control between 25~30 DEG C, fermentation time control between 20~40d.
8. a kind of Chinese medicine composition for treating cardiovascular disease according to claim 1, it is characterised in that: the step F
Broken wall carried out in pulverizer, and the mating sieve for being provided with 400~600 mesh of pulverizer.
9. a kind of Chinese medicine composition for treating cardiovascular disease according to claim 1, it is characterised in that: the step G
In, every bottle of filling mixing liquid hold-up is between 10~20ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811472476.XA CN109260447A (en) | 2018-11-30 | 2018-11-30 | A kind of Chinese medicine composition for treating cardiovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811472476.XA CN109260447A (en) | 2018-11-30 | 2018-11-30 | A kind of Chinese medicine composition for treating cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109260447A true CN109260447A (en) | 2019-01-25 |
Family
ID=65186797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811472476.XA Pending CN109260447A (en) | 2018-11-30 | 2018-11-30 | A kind of Chinese medicine composition for treating cardiovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109260447A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111298084A (en) * | 2020-03-25 | 2020-06-19 | 杭州迹童精密机械有限公司 | A Chinese medicinal composition for treating cardiovascular diseases |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1698749A (en) * | 2005-04-25 | 2005-11-23 | 高乾林 | Medicinal wine with aizoon stonecrop for treating blood vessel disease and its preparation method |
| CN1840149A (en) * | 2006-01-19 | 2006-10-04 | 邢法田 | Medicinal pill for treating cardiovascular and cerebrovascular disease and its preparing process |
| CN1990033A (en) * | 2005-12-28 | 2007-07-04 | 张翀 | Drug for treating hypertension, dense blood and arteriosclerosis |
| CN101297917A (en) * | 2008-06-16 | 2008-11-05 | 广东宏兴集团股份有限公司宏兴制药厂 | Chinese medicinal composition for treating hyperlipemia and preparation thereof |
| CN101897755A (en) * | 2010-07-28 | 2010-12-01 | 尹传海 | Traditional Chinese medicine preparation for regulating fat, invigorating blood circulation and regulating vital energy and preparation method thereof |
-
2018
- 2018-11-30 CN CN201811472476.XA patent/CN109260447A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1698749A (en) * | 2005-04-25 | 2005-11-23 | 高乾林 | Medicinal wine with aizoon stonecrop for treating blood vessel disease and its preparation method |
| CN1990033A (en) * | 2005-12-28 | 2007-07-04 | 张翀 | Drug for treating hypertension, dense blood and arteriosclerosis |
| CN1840149A (en) * | 2006-01-19 | 2006-10-04 | 邢法田 | Medicinal pill for treating cardiovascular and cerebrovascular disease and its preparing process |
| CN101297917A (en) * | 2008-06-16 | 2008-11-05 | 广东宏兴集团股份有限公司宏兴制药厂 | Chinese medicinal composition for treating hyperlipemia and preparation thereof |
| CN101897755A (en) * | 2010-07-28 | 2010-12-01 | 尹传海 | Traditional Chinese medicine preparation for regulating fat, invigorating blood circulation and regulating vital energy and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111298084A (en) * | 2020-03-25 | 2020-06-19 | 杭州迹童精密机械有限公司 | A Chinese medicinal composition for treating cardiovascular diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111743934A (en) | Traditional Chinese medicine composition for regulating intestinal flora and application thereof | |
| CN1977908A (en) | Chinese medicine composition for treating cardio-cerebrovascular disease | |
| CN101037651A (en) | Lucidum mushroom health wine and production method thereof | |
| CN109260447A (en) | A kind of Chinese medicine composition for treating cardiovascular disease | |
| CN1698804A (en) | Traditional Chinese medicine preparation for treating thoracic obstruction and palpitation and preparation method thereof | |
| CN1965996A (en) | Preparation method of Chinese medicinal capsule for treating apoplexy | |
| CN106135829A (en) | A kind of production method of mulberry enzyme | |
| CN102485266A (en) | Formula of five-tree sap oral liquid having effects of enhancing immunity, delaying senescence, maintaining beauty and keeping young | |
| CN107320658A (en) | A kind of tea-drinking of hypotensive | |
| CN103417624A (en) | Health wine for preventing high blood pressure, high cholesterol, high blood sugar, cardiovascular and cerebrovascular diseases and various tumors | |
| CN106561849A (en) | Preparation method of tea leaves with health care effect | |
| CN103041323A (en) | Chinese medicinal liniment for treating alopecia | |
| CN108159191B (en) | Composition for tonifying yang and invigorating kidney, application and oral liquid and preparation method thereof | |
| CN1135997C (en) | 'Shexingkeyu' capsule for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN104013686B (en) | A kind of medicine being used for the treatment of prolapse of lumbar intervertebral disc and preparation method thereof | |
| CN104435368A (en) | Radiation-proof Chinese medicinal preparation as well as preparation method and application thereof | |
| CN110522798A (en) | A kind of compound preparation and preparation method thereof curing mainly coronary heart disease | |
| CN110090249A (en) | Prevent and treat the Chinese medicine composition and the preparation method and application thereof of hypertension | |
| CN105055856B (en) | A kind of Tea Pigment Chinese medicine composition and its preparation method and application for treating cardiovascular and cerebrovascular disease | |
| CN108355052A (en) | A kind of drug and preparation method thereof treated leucocyte after chemicotherapy and reduced | |
| CN107927745B (en) | A Chinese medicinal health food composition, and its preparation method and preparation | |
| CN101803650A (en) | Compound gingko health protection tea and preparation method thereof | |
| CN1907315A (en) | Orthopaedics disease treating and preventing medicinal composition | |
| CN107737045A (en) | A kind of fat reducing body lotion | |
| CN105169148B (en) | It is a kind of to treat dyspeptic Chinese medicine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190125 |
|
| RJ01 | Rejection of invention patent application after publication |